Literature DB >> 30100081

Amino Acid Metabolism as a Target for Breast Cancer Imaging.

Gary A Ulaner1, David M Schuster2.   

Abstract

Amino acids are an alternate energy source to glucose, and amino acid metabolism is up-regulated in multiple malignancies, including breast cancers. Multiple amino acid radiotracers have been used to image breast cancer with unique strengths and weaknesses. 11C-methionine uptake correlates with S-phase fraction in breast cancer and may be useful for evaluation of treatment response. Invasive lobular breast cancers may demonstrate greater 18F-fluciclovine avidity than 18F-fluorodeoxyglucose. Thus, different histologic subtypes of breast cancer may use diverse metabolic pathways and may be better imaged by different tracers.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amino acid; Breast cancer; Fluciclovine; Methionine; PET/CT

Mesh:

Substances:

Year:  2018        PMID: 30100081      PMCID: PMC6092023          DOI: 10.1016/j.cpet.2018.02.009

Source DB:  PubMed          Journal:  PET Clin        ISSN: 1556-8598


  57 in total

1.  Specific PET imaging of xC- transporter activity using a ¹⁸F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism.

Authors:  Norman Koglin; Andre Mueller; Mathias Berndt; Heribert Schmitt-Willich; Luisella Toschi; Andrew W Stephens; Volker Gekeler; Matthias Friebe; Ludger M Dinkelborg
Journal:  Clin Cancer Res       Date:  2011-07-12       Impact factor: 12.531

2.  Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer.

Authors:  Eugene J Teoh; Maria T Tsakok; Kevin M Bradley; Katherine Hyde; Manil Subesinghe; Fergus V Gleeson
Journal:  Clin Nucl Med       Date:  2017-10       Impact factor: 7.794

Review 3.  Expanding the view of breast cancer metabolism: Promising molecular targets and therapeutic opportunities.

Authors:  John P Harrelson; Michael W Lee
Journal:  Pharmacol Ther       Date:  2016-08-04       Impact factor: 12.310

4.  Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.

Authors:  Molly P Hogan; Debra A Goldman; Brittany Dashevsky; Christopher C Riedl; Mithat Gönen; Joseph R Osborne; Maxine Jochelson; Clifford Hudis; Monica Morrow; Gary A Ulaner
Journal:  J Nucl Med       Date:  2015-08-20       Impact factor: 10.057

5.  Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]tyrosine PET.

Authors:  A C Kole; O E Nieweg; J Pruim; A M Paans; J T Plukker; H J Hoekstra; H Schraffordt Koops; W Vaalburg
Journal:  J Nucl Med       Date:  1997-05       Impact factor: 10.057

6.  Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers.

Authors:  Gary A Ulaner; Debra A Goldman; Adriana Corben; Serge K Lyashchenko; Mithat Gönen; Jason S Lewis; Maura Dickler
Journal:  J Nucl Med       Date:  2016-11-17       Impact factor: 10.057

7.  Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

Authors:  N Avril; M Menzel; J Dose; M Schelling; W Weber; F Jänicke; W Nathrath; M Schwaiger
Journal:  J Nucl Med       Date:  2001-01       Impact factor: 10.057

8.  Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts.

Authors:  Sharon K Michelhaugh; Otto Muzik; Anthony R Guastella; Neil V Klinger; Lisa A Polin; Hancheng Cai; Yangchun Xin; Thomas J Mangner; Shaohui Zhang; Csaba Juhász; Sandeep Mittal
Journal:  J Nucl Med       Date:  2016-10-20       Impact factor: 10.057

9.  PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.

Authors:  Brian P Lieberman; Karl Ploessl; Limin Wang; Wenchao Qu; Zhihao Zha; David R Wise; Lewis A Chodosh; George Belka; Craig B Thompson; Hank F Kung
Journal:  J Nucl Med       Date:  2011-11-15       Impact factor: 10.057

10.  Synthesis and evaluation of amino acid-based radiotracer 99mTc-N4-AMT for breast cancer imaging.

Authors:  Fan-Lin Kong; Mohammad S Ali; Yinhan Zhang; Chang-Sok Oh; Dong-Fang Yu; Mithu Chanda; David J Yang
Journal:  J Biomed Biotechnol       Date:  2011-04-07
View more
  5 in total

1.  [18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0.

Authors:  Cristina Nanni; Lucia Zanoni; Tore Bach-Gansmo; Heikki Minn; Frode Willoch; Trond Velde Bogsrud; Ephraim Parent Edward; Bital Savir-Baruch; Eugene Teoh; Fenton Ingram; Stefano Fanti; David M Schuster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-11       Impact factor: 9.236

2.  Identification of Metabolic Alterations in Breast Cancer Using Mass Spectrometry-Based Metabolomic Analysis.

Authors:  Sili Fan; Muhammad Shahid; Peng Jin; Arash Asher; Jayoung Kim
Journal:  Metabolites       Date:  2020-04-24

Review 3.  Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy.

Authors:  Evelien A J van Genugten; Jetty A M Weijers; Sandra Heskamp; Manfred Kneilling; Michel M van den Heuvel; Berber Piet; Johan Bussink; Lizza E L Hendriks; Erik H J G Aarntzen
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

4.  Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review.

Authors:  Michele Balma; Virginia Liberini; Manuela Racca; Riccardo Laudicella; Matteo Bauckneht; Ambra Buschiazzo; Daniele Giovanni Nicolotti; Simona Peano; Andrea Bianchi; Giovanni Albano; Natale Quartuccio; Ronan Abgral; Silvia Daniela Morbelli; Calogero D'Alessandria; Enzo Terreno; Martin William Huellner; Alberto Papaleo; Désirée Deandreis
Journal:  Front Med (Lausanne)       Date:  2022-04-12

Review 5.  Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs.

Authors:  Fereydoon Abedi-Gaballu; Elham Kamal Kazemi; Seyed Ahmad Salehzadeh; Behnaz Mansoori; Farhad Eslami; Ali Emami; Gholamreza Dehghan; Behzad Baradaran; Behzad Mansoori; William C Cho
Journal:  Cells       Date:  2022-09-23       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.